Clinical Trials Browser

Hodgkin Disease, Lymphoma, Leukemia, Myelomonocytic, Chronic, Lymphoma, Large B-Cell, Diffuse

Hodgkin Disease, Recurrence

Cholangiocarcinoma

Phase 2 Study

Carcinoma, Transitional Cell

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms, Carcinoma, Transitional Cell

Carcinoma, Non-Small-Cell Lung

Neoplasm Metastasis

Pancreatic Neoplasms

Nasopharyngeal Carcinoma

Neoplasm Metastasis

Pancreatic Adenocarcinoma

Pancreatic Neoplasms

Urinary Bladder Neoplasms

Biliary Tract Neoplasms

Lung Neoplasms

Pancreatic Neoplasms

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms

Carcinoma, Non-Small-Cell Lung

Biliary Tract Neoplasms

Cholangiocarcinoma

Pancreatic Neoplasms, Neoplasms, Basal Cell

Lymphoma, Large B-Cell, Diffuse

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms

Metastatic Pancreatic Ductal Adenocarcinoma

Advanced Biliary Tract Carcinoma

Advanced Biliary Tract Carcinoma

Nasopharyngeal Carcinoma

Breast Neoplasms

Nasopharyngeal Carcinoma

Gallbladder Neoplasms, Cholangiocarcinoma

Urinary Bladder Neoplasms

Nasopharyngeal Carcinoma

Pancreatic Neoplasms

Locally Advanced Pancreatic Cancer

Osteosarcoma

Urinary Bladder Neoplasms

Leiomyosarcoma, Sarcoma

Lung Neoplasms

Pancreatic Neoplasms

Hodgkin Disease, Recurrence

Pancreatic Neoplasms

Bile Duct Neoplasms, Cholangiocarcinoma

Biliary Tract Neoplasms

Pancreatic Neoplasms

Carcinoma, Transitional Cell

Brain Neoplasms, Breast Neoplasms

Clinical Trials

Ascorbic Acid and Chemotherapy for the Treatment of Relapsed or Refractory Lymphoma, CCUS, and Chronic Myelomonocytic Leukemia

Phase II Study of Second- Line Pembrolizumab Plus GVD for Relapsed or Refractory Hodgkin Lymphoma

A Single-Arm Study of Pembrolizumab With Gemcitabine and Cisplatin as Perioperative Therapy for Potentially Resectable Intrahepatic Cholangiocarcinoma

A Phase II Study Evaluating BMS-986504 in MTAP-deleted Pancreatic Cancer

A Study of BMS-986504 With Standard-of-Care Therapy for People With Solid Tumor Cancer

ADAPT-BLADDER

Reduced-dose Carboplatin-doublet-chemotherapy + Cemiplimab vs Cemiplimab Monotherapy in Treatment Naive Older and Frail Patients With Metastatic NSCLC With PD-L1 <50%

Retifanlimab (Anti-PD-1 Antibody) With Gemcitabine and Docetaxel in Patients With Advanced Soft Tissue Sarcoma

Valproic Acid/Simvastatin Plus Gemcitabine/Nab-paclitaxel Based Regimens in Untreated Metastatic Pancreatic Adenocarcinoma Patients

Gemcitabine and Leflunomide in Patients With Advanced Unresectable Pancreatic Cancer

LIGHT

SWITCH

A Study of NovoTTF-200T(P) in Combination With Gemcitabine and Nab-Paclitaxel for Resectable Pancreatic Adenocarcinoma

LAP100

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study

HAIC Plus Systemic Therapy as De-escalation Therapy Strategy for Biliary Tract Cancer

Comparing Impact of Treatment Before or After Surgery in Patients With Stage II-IIIB Resectable Non-small Cell Lung Cancer

Perioperative Fostamatinib With Gemcitabine and Nab-paclitaxel in Resectable Pancreatic Cancer

GAIN-BCG

IMMUNOLIFE2

Emavusertib (CA-4948) in Combination With Cisplatin, Gemcitabine, and Durvalumab in Patients With Untreated Advanced or Metastatic Biliary Tract Cancer

Gemcitabine and Oxaliplatin Chemotherapy With or Without a Floxuridine and Dexamethasone Pump in People With Cholangiocarcinoma That Cannot Be Removed With Surgery

PANGEA

Low Dose Epcoritamab Plus GemOx in R/R DLBCL

In-home Intravesical Chemotherapy for the Treatment of Bladder Cancer, INVITE Trial

ONT01 and Gemcitabine/Nab-paclitaxel as Second Line Therapy for Metastatic Pancreatic Ductal Adenocarcinoma

TACTIC

Adebrelimab Combined With Gemcitabine, Cisplatin, and Simvastatin for Advanced Biliary Tract Cancer

IC Plus Low-dose Radiation Plus Cadonilimab in LANPC

The Efficacy and Safety of Trastuzumab Rezetecan (SHR-A1811) in HER2-Low Unresectable/Metastatic Breast Cancer Patients With Visceral Crisis

Becotatug Vedotin Plus Sintilimab in Locoregionally Advanced NPC

Pressurized Intraperitoneal Aerosolized Nab-Paclitaxel in Combination With Gemcitabine and Cisplatin for the Treatment of Biliary Tract Cancer Patients With Peritoneal Metastases

Intravesical Gemcitabine and Docetaxel for Low Grade Intermediate Risk Bladder Cancer

Reduced-dose Radiotherapy for Stage III Nasopharyngeal Carcinoma Based on the Treatment Response

PANCREAS

Phase I Nab-Paclitaxel Plus Gemcitabine With Proton Therapy for Locally Advanced Pancreatic Cancer (LAPC)

Tegavivint With Gemcitabine in Patients With Relapsed or Refractory Osteosarcoma

Intravesical Gem/Doce in Patients With NMIBC

A Phase I Trial of Combination Gemcitabine and Nab-Sirolimus in Advanced Leiomyosarcomas or Advanced Soft-Tissue Sarcomas With TSC2 or TSC1 Loss-of-function Mutations or Deletions

Local Consolidative Therapy and Durvalumab for Oligoprogressive and Polyprogressive Stage III NSCLC After Chemoradiation and Anti-PD-L1 Therapy

Biologically Optimized Infusion Schedule of Gemcitabine and Nab-Paclitaxel for the Treatment of Metastatic Pancreatic Cancer

FIL_A-BEGEV

QL1706 Plus Chidamide, AG as First-line Treatment for Metastatic Pancreatic Cancer

Study of Gemcitabine, Cisplatin, AB680 and AB122 During First Line Treatment of Advanced Biliary Tract Cancers (QUIC)

MAGNATE-S

CTX-009 With Gemcitabine, Cisplatin, and Durvalumab as First-line Therapy in Patients With Unresectable or Metastatic Biliary Tract Cancers

LUNG-05

PANC

Adjuvant Radioimmunotherapy Compared With Adjuvant Chemotherapy for UTUC

SOLARA